Compare MOLN & MINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | MOLN | MINE |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | Switzerland | Canada |
| Employees | N/A | 9 |
| Industry | | Oil & Gas Production |
| Sector | | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.2M | 163.8M |
| IPO Year | 2021 | N/A |
| Metric | MOLN | MINE |
|---|---|---|
| Price | $4.12 | $2.62 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.38 | N/A |
| AVG Volume (30 Days) | 1.1K | ★ 19.7K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $374.07 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.46 | $2.16 |
| 52 Week High | $5.36 | $4.45 |
| Indicator | MOLN | MINE |
|---|---|---|
| Relative Strength Index (RSI) | 52.06 | 62.13 |
| Support Level | $3.94 | $2.59 |
| Resistance Level | $4.13 | $2.87 |
| Average True Range (ATR) | 0.07 | 0.13 |
| MACD | 0.01 | 0.04 |
| Stochastic Oscillator | 62.28 | 95.85 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Mayfair Gold Corp is a mineral exploration company that is engaged in the acquisition and exploration of mineral properties. It has one material mineral property, the Fenn-Gib Gold Property, located in the Guibord, Munro, Michaud, and McCool Townships in northeast Ontario, which is in the exploration stage.